Irritable Bowel Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Other: Face-to-face hypnotherapy; Other: Online hypnotherapy; Other: Online psychoeducation Sponsors: Maastricht University Medical Center; ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials
The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers
Condition: Irritable Bowel Syndrome Interventions: Other: Gluten-free diet with gluten powder; Other: Gluten-free diet with placebo powder Sponsor: Sahlgrenska University Hospital, Sweden Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2019 Category: Research Source Type: clinical trials
Panaceo " MED " for IBS (Irritable Bowel Syndrome)
Conditions: Irritable Bowel Syndrome; Microbial Colonization; Intestinal Disease Intervention: Other: Zeolite Sponsor: Scigenia GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition: Irritable Bowel Syndrome With Diarrhea Intervention: Other: Pan Capsule and colonoscopy in patients with IBS Sponsors: Hospital Avicenne; Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Interventions: Drug: Vibegron; Drug: Placebo Sponsor: Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials
